Other
Revenue
Neurocrine Biosciences Revenue increased by 1.1% to $814.50M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 42.2%, from $572.60M to $814.50M. Over 4 years (FY 2021 to FY 2025), Revenue shows an upward trend with a 26.0% CAGR. This is a positive signal — higher values indicate stronger performance for this metric.
Analysis
StatementCash Flow Statement
SectionOther
CategoryGrowth
SignalHigher is better
VolatilityStable
First reportedQ1 2016
Last reportedQ1 2026May 5, 2026
How to read this metric
Growth indicates successful market penetration, pricing power, or volume expansion, while a decline suggests weakening demand or competitive pressure.
Detailed definition
This represents the total gross revenue generated from the sale of goods and services to customers, excluding any sales-...
Peer comparison
The standard top-line revenue metric used across all public companies for financial reporting.
Metric ID:
other_revenue_from_contract_with_customer_excluding_asse_0d5b70Historical Data
20 periods
| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $288.90M | $296.00M | $312.00M | $310.60M | $378.20M | $387.90M | $412.00M | $420.40M | $452.70M | $498.80M | $515.20M | $515.30M | $590.20M | $622.10M | $627.70M | $572.60M | $687.50M | $794.90M | $805.50M | $814.50M |
| QoQ Change | — | +2.5% | +5.4% | -0.4% | +21.8% | +2.6% | +6.2% | +2.0% | +7.7% | +10.2% | +3.3% | +0.0% | +14.5% | +5.4% | +0.9% | -8.8% | +20.1% | +15.6% | +1.3% | +1.1% |
| YoY Change | — | — | — | — | +30.9% | +31.0% | +32.1% | +35.4% | +19.7% | +28.6% | +25.0% | +22.6% | +30.4% | +24.7% | +21.8% | +11.1% | +16.5% | +27.8% | +28.3% | +42.2% |
Range$288.90M – $814.50M
CAGR+24.4%
Avg YoY Growth+26.8%
Median YoY Growth+28.1%
Current Streak4 quarters growth
Revenue at Other Companies
Frequently Asked Questions
- What is Neurocrine Biosciences's revenue?
- Neurocrine Biosciences (NBIX) reported revenue of $814.50M in Q1 2026.
- How has Neurocrine Biosciences's revenue changed year-over-year?
- Neurocrine Biosciences's revenue increased by 42.2% year-over-year, from $572.60M to $814.50M.
- What is the long-term trend for Neurocrine Biosciences's revenue?
- Over 4 years (2021 to 2025), Neurocrine Biosciences's revenue has grown at a 26.0% compound annual growth rate (CAGR), from $1.13B to $2.86B.
- What does revenue mean?
- Total sales revenue earned from customers, excluding collected sales taxes.